| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.062 | 0.6 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |